AI is reshaping clinical research faster than any technology before it; but for sponsors and CROs, adoption without GxP-grade governance, validation, and human oversight isn't a strategy. It's a risk.
Philip Raeth
Advertisement
Philip Raeth is Managing Director at Palleos.
Articles by Philip Raeth
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Compliance: AJNA BioSciences' Joel Stanley on Bringing Botanical Medicine Through the FDA Pathway
2
Where AI Is Delivering Real Value in Clinical Trial Payments Right Now
3
ACT Brief: AI in Invoice Processing, Botanical Medicines and FDA Pathways, and Connected Trial Finance Systems
4
From Doing to Reviewing: How a Connected Ecosystem Streamlines Clinical Trial Finance
5